JP Morgan Chase
HQL

JP Morgan Chase’s abrdn Life Sciences Investors HQL Stock Holding History

JP Morgan Chase’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32 Buy
+2
New +$33 ﹤0.01% 7387
2025
Q2 		– Sell
-5
Closed -$63 – 7333
2025
Q1 		$63 Buy
+5
New +$68 ﹤0.01% 6939
2024
Q4 		– Sell
-2
Closed -$30 – 7536
2024
Q3 		$30 Hold
2
– – ﹤0.01% 7200
2024
Q2 		$28 Hold
2
– – ﹤0.01% 7123
2024
Q1 		$27 Sell
2
-8,103
-100% -$112K ﹤0.01% 7129
2023
Q4 		$109K Buy
8,105
+8,104
+810,400% +$99.7K ﹤0.01% 5698
2023
Q3 		$12 Sell
1
-20,710
-100% -$272K ﹤0.01% 7264
2023
Q2 		$280K Buy
20,711
+20,709
+1,035,450% +$286K ﹤0.01% 4870
2023
Q1 		$0 Buy
2
+1
+100% +$14 ﹤0.01% 6942
2022
Q4 		$0 Buy
+1
New +$14 ﹤0.01% 6743
2022
Q2 		– Sell
-4
Closed – – 6646
2022
Q1 		$0 Hold
4
– – ﹤0.01% 6779
2021
Q4 		$0 Buy
4
+3
+300% +$60 ﹤0.01% 6781
2021
Q3 		$0 Buy
+1
New +$21 ﹤0.01% 6626
2021
Q2 		– Sell
-3
Closed – – 6448
2021
Q1 		$0 Buy
3
+2
+200% +$41 ﹤0.01% 6183
2020
Q4 		$0 Sell
1
-1
-50% -$18 ﹤0.01% 5753
2020
Q3 		$0 Hold
2
– – ﹤0.01% 5593
2020
Q2 		$0 Buy
+2
New +$34 ﹤0.01% 5514
2019
Q4 		– Sell
-2
Closed – – 5728
2019
Q3 		$0 Buy
2
+1
+100% +$16 ﹤0.01% 5832
2019
Q2 		$0 Hold
1
– – ﹤0.01% 5857
2019
Q1 		$0 Buy
+1
New +$17 ﹤0.01% 5893
2017
Q1 		– Sell
-20
Closed – – 5127
2016
Q4 		$0 Buy
+20
New +$351 ﹤0.01% 5056
2016
Q2 		– Sell
-11
Closed – – 4860
2016
Q1 		$0 Buy
+11
New +$200 ﹤0.01% 4794
2014
Q1 		– Sell
-26,510
Closed -$542K – 3731
2013
Q4 		$542K Buy
+26,510
New +$514K ﹤0.01% 3451

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase's HQL Position: Q1 2026 in Review

JP Morgan Chase opened a new position in abrdn Life Sciences Investors (HQL) in Q1 2026: 2 shares worth $32. The stake represents ﹤0.01% of the portfolio and ranks #7387 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in HQL as recently as Q1 2025.

JP Morgan Chase first reported a position in HQL in Q4 2013 and has held it in 23 quarters since. The position peaked at $542K in Q4 2013. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • JP Morgan Chase held 2 shares of abrdn Life Sciences Investors worth $32 as of Q1 2026.
  • abrdn Life Sciences Investors was a new JP Morgan Chase position in Q1 2026.
  • abrdn Life Sciences Investors made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7387 holding.
  • JP Morgan Chase first reported a position in abrdn Life Sciences Investors in Q4 2013 and has held it in 23 quarters since.
  • JP Morgan Chase's abrdn Life Sciences Investors position peaked at $542K in Q4 2013.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.